📢 Advancing Veterinary Medicine at #bptKongress2024. 🌍🐾 MEDEA Biopharma was honored to present our innovative bacteriophage-based solutions at the #bptKongress2024 in Hannover, which brought together nearly 3,400 professionals dedicated to advancing animal health. 🦠🐕 As one of 162 exhibitors from 11 countries, we showcased our cutting-edge approach to combating bacterial infections in animals, engaging with veterinarians and industry leaders. We thank the organizers and all attendees for the inspiring conversations and the shared commitment to innovation in veterinary medicine. Together, we are shaping the future of animal health. Bundesverband Praktizierender Tierärzte e.V. #Innovation #AnimalHealth #Bacteriophages #VeterinaryMedicine #MEDEABiopharma #bptKongress2024 #Phages Quellenangabe: bpt/Rathke
MEDEA Biopharma
Biotechnologieforschung
Ludwigshafen, Rhineland-Palatinate 1.131 Follower:innen
Developing new generation of sustainable antibacterial solutions.
Info
Medea Biopharma GmbH, a German biotech company based in Ludwigshafen, Germany, was co-founded by Rüdiger Trojok, Dr. Elene Kakabadze, and Giorgi Khubua. Medea Biopharma GmbH specializes in the development of a new generation of sustainable and eco-friendly antibacterial solutions based on bacteriophages (phages), designed to solve the global crisis of antimicrobial resistance. Phages are natural bacterial killers, which are highly specific and without side effects. These innovative alternatives aim to replace conventional chemical antibiotics, copper-based solutions, and harmful pesticides, offering effective and environmentally responsible ways to combat harmful bacteria across diverse sectors, including human health, animal well-being, and agriculture.
- Website
-
www.medea-bio.com
Externer Link zu MEDEA Biopharma
- Branche
- Biotechnologieforschung
- Größe
- 2–10 Beschäftigte
- Hauptsitz
- Ludwigshafen, Rhineland-Palatinate
- Art
- Privatunternehmen
- Gegründet
- 2023
Orte
-
Primär
Donnersbergweg 1
Ludwigshafen, Rhineland-Palatinate 67059, DE
Beschäftigte von MEDEA Biopharma
Updates
-
🚀 We have presented MEDEA Biopharma’s vision and groundbreaking bacteriophage-based antibacterial solutions at 𝐒𝐋𝐈𝐍𝐆𝐒𝐇𝐎𝐓 2024! 🌍 Being among the #𝐓𝐎𝐏50 𝐒𝐭𝐚𝐫𝐭𝐮𝐩𝐬 out of 5.600 applications in Asia’s largest deep-tech startup competition has been a fantastic opportunity to connect, learn, and showcase our commitment to combating antimicrobial resistance with sustainable, safe and natural antibacterial solutions. 🌱🔬 A big thank you to everyone at 𝐒𝐈𝐍𝐆𝐀𝐏𝐎𝐑𝐄 𝐖𝐞𝐞𝐤 𝐨𝐟 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 (𝐒𝐖𝐈𝐓𝐂𝐇) for the incredible experience and the chance to stand alongside innovators and industry leaders! 💡 #biotech #startup #antimicrobialresistance #AMR #SLINGSHOT2024 #phages #bacteriophages #SWITCH2024
-
MEDEA Biopharma will be exhibiting at the #bptVetCongress in Hannover, Germany from 15th to 16th November! 🐾🌍 Come find us at 𝐁𝐨𝐨𝐭𝐡 𝐅20, where we’ll be sharing insights on the potential of 𝐛𝐚𝐜𝐭𝐞𝐫𝐢𝐨𝐩𝐡𝐚𝐠𝐞𝐬 in treating infections and paving the way for an 𝐚𝐧𝐭𝐢𝐦𝐢𝐜𝐫𝐨𝐛𝐢𝐚𝐥 𝐫𝐞𝐬𝐢𝐬𝐭𝐚𝐧𝐜𝐞-𝐟𝐫𝐞𝐞 𝐟𝐮𝐭𝐮𝐫𝐞. 🦠💡 #BptVetCongress #AnimalHealth #Bacteriophages #Innovation #AntimicrobialResistance #MEDEABiopharma #phages
-
MEDEA Biopharma hat dies direkt geteilt
🌍 A proud moment for MEDEA Biopharma ! Our Co-founder, Rüdiger Trojok, had the honor of meeting Bundespräsident Frank-Walter Steinmeier and Ministerpräsident of Rheinland-Pfalz Alexander Schweitzer at the DBU Deutsche Bundesstiftung Umwelt conference, where the prestigious Deutscher Umweltpreis was awarded. This €500,000 award is a significant recognition of outstanding dedication and achievements that contribute to protecting and preserving our environment, now and in the future. It honors individuals whose innovative products, technical process improvements, successful research, or lifelong contributions stand as models of sustainable environmental protection. The award ceremony took place on October 27th, 2024, in the Rheingoldhalle in Mainz and was awarded to Dr. Franziska Tanneberger and Dipl.-Ing. Thomas Speidel. Congratulations to the inspiring winners, who pave the way for a more sustainable future! 🌱 #MedeaBiopharma #DeutscherUmweltpreis #EnvironmentalProtection #Innovation #Sustainability
-
🌍 A proud moment for MEDEA Biopharma ! Our Co-founder, Rüdiger Trojok, had the honor of meeting Bundespräsident Frank-Walter Steinmeier and Ministerpräsident of Rheinland-Pfalz Alexander Schweitzer at the DBU Deutsche Bundesstiftung Umwelt conference, where the prestigious Deutscher Umweltpreis was awarded. This €500,000 award is a significant recognition of outstanding dedication and achievements that contribute to protecting and preserving our environment, now and in the future. It honors individuals whose innovative products, technical process improvements, successful research, or lifelong contributions stand as models of sustainable environmental protection. The award ceremony took place on October 27th, 2024, in the Rheingoldhalle in Mainz and was awarded to Dr. Franziska Tanneberger and Dipl.-Ing. Thomas Speidel. Congratulations to the inspiring winners, who pave the way for a more sustainable future! 🌱 #MedeaBiopharma #DeutscherUmweltpreis #EnvironmentalProtection #Innovation #Sustainability
-
🔬 As a member of bioRN Life Science Cluster Rhine-Neckar, we had the pleasure of being part of the 15th #BioRN Annual Conference, where MEDEA Biopharma was represented by our Head of Research and Development, 𝐃𝐫. Michael Plank. With almost 500 registrations and over 30 exhibitors, the event provided a fantastic platform to engage with the innovative life sciences community. Many thanks to Gitte Neubauer and Julia Schaft for kicking off the event and leading insightful discussions. We look forward to continued collaboration and advancement in the biotech space. #LifeSciences #BioRN #Innovation #Networking #Biotech #Phages #Bacteriophages Pictures: bioRN Life Science Cluster Rhine-Neckar
-
+1
-
🏆 We are excited to be among the 𝐓𝐎𝐏 50 𝐒𝐭𝐚𝐫𝐭𝐮𝐩𝐬 at #SLINGSHOT2024, standing out among more than 5,000 𝐜𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐨𝐫𝐬! 🌍🚀 𝐒𝐋𝐈𝐍𝐆𝐒𝐇𝐎𝐓, Asia’s one of the largest #deeptech #startup competitions, will be held as part of Asia’s leading startup and innovation festival, 𝐒𝐢𝐧𝐠𝐚𝐩𝐨𝐫𝐞 𝐖𝐞𝐞𝐤 𝐨𝐟 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 (𝐒𝐖𝐈𝐓𝐂𝐇) 2024, taking place in Singapore from October 28 to 30, 2024. Looking forward connect with innovators and industry leaders as we showcase our bacteriophage-based sustainable antibacterial solutions — a new generation of natural and effective approaches to combat antimicrobial resistance and bacterial threats. 💡🔬 #Biotechnology #DeepTech #Bacteriophages #Phages #AMR #Sustainability #SLINGSHOT2024 #SWITCH2024
-
🚀 Phages in Space! 🪐 Last week, Rüdiger Trojok presented MEDEA Biopharma's cutting-edge solutions at the event of European Space Agency - ESA. 🌍 As the humanity prepares for long-duration space missions, like travel to Mars and establishing lunar habitats, the Phage therapy is gaining significant interest as a lifesaving treatment option when antibiotic therapies fail and antimicrobial resistance evolves—especially in environments where Earth-based medical support is out of reach. 🧬Personalised phage therapy can not only protect astronaut health but also prevent mission-critical failures. #Biotech #PhageTherapy #SpaceExploration #ESA #Innovation #Healthcare
-
🚀 Major achievements for MEDEA Biopharma and for the whole German Startup Ecosystem! 🧬💡 MEDEA Biopharma was selected as one of the 16 winners at the #StartupGermanySummit2024, proudly representing Rheinland-Pfalz. This recognition highlights the significance of our approach and the critical importance of tackling antibiotic resistance. 📈 Major highlight of the event was the introduction of WIN, an initiative aimed at boosting venture and growth capital in Germany. This program advocates for improved investment conditions in the tech and green tech sectors, with the goal of mobilizing more private capital for the VC asset class - including a plan to invest €12 billion in institutional capital by 2030. The agreement was signed in Berlin by Chancellor Olaf Scholz, Finance Minister Christian Lindner, and Economy Minister Robert Habeck, along with key partners such as Allianz, BlackRock, Bayerische Versorgungskammer, Deutsche Bank, Deutsche Telekom, and the Startup-Verband. Together, we are building a stronger future for innovation and entrepreneurship in Germany. 🚀 Commerzbank AG Munich Re DSGV - Deutscher Sparkassen- und Giroverband Barmenia Versicherungen Gothaer VGH Versicherungen Deutsche Börse Versicherungskammer Bayern DZ BANK AG AXA Stuttgarter Lebensversicherung a.G. Frankfurt School of Finance & Management European School of Management and Technology Henkel DB Schenker Generali Deutschland AG Bertelsmann SE & Co. KGaA caesar. Helmut Schoenenberger Stefan Drüssler Dr. Carolin Gabor Investitions- und Strukturbank Rheinland-Pfalz (ISB) Mike Walber Gregor Henrik Unger UnternehmerTUM Rüdiger Trojok Giorgi Khubua Rheinland-Pfalz Gold #AntibioticResistance #BiotechInnovation #StartupGermany #GrowthFunding #TechForGood #MEDEABiopharma #RheinlandPfalz #WINInitiative Copyright: Christina Czybik, bundesfoto, BMWK
-
+5
-
🌟 MEDEA Biopharma was part of #Curious2024 Future Insight Conference! Organized by Future Insight e.V. and launched by Ulrich Betz from Merck Group, the event focused on breakthrough science topics various areas. 🌍 With 1600 on-site and over 3700 total attendees from 40+ countries, 130 speakers including Ugur Sahin from BioNTech SE and 7 Nobel laureates, the conference offered deep insights about scientific achievements and challenges, among others the antimicrobial resistance, bacteriophages and their potential. Big thanks to the Ministerium für Wirtschaft, Verkehr, Landwirtschaft und Weinbau Rheinland-Pfalz for inviting MEDEA Biopharma! #Bacteriophages #FutureScience #Breakthroughs #Sustainability
Ähnliche Seiten
Finanzierung
Letzte Runde
Unterstützung ohne FremdkapitalInvestor:innen
MassChallenge Switzerland